Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 96

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 96
---
 the factors considered by Aadi’s board of directors is not intended to be exhaustive, but does set forth the material factors considered by Aadi’s board of directors. Aadi’s board of directors reached the unanimous conclusion to approve the Divestiture Agreement in light of the various factors described above and other factors that each member of Aadi’s board of directors felt were appropriate. In view of the wide variety of factors considered by Aadi’s board of directors in connection with its evaluation of the Divestiture and the complexity of these matters, Aadi’s board of directors did not consider it practical, and did not attempt to quantify, rank or otherwise assign relative weights to the specific factors it considered in reaching its decision and did not undertake to make any specific determination as to whether any particular factor, or any aspect of any particular factor, was favorable or unfavorable to the ultimate determination of Aadi’s board of directors. Rather, the recommendation of Aadi’s board of directors was based on the totality of information presented to it and the investigation conducted by it. In considering the factors discussed above, individual directors may have given different weights to different factors. Portions of this explanation of the reasons for the Divestiture and other information presented in this section are forward-looking in nature and, therefore, should be read in light of the section entitled “ Special Note Regarding Forward-Looking Statements.” - 62 -

Opinion of Leerink Partners LLC Introduction Aadi retained Leerink Partners as its financial advisor in connection with the Divestiture contemplated by the Divestiture Agreement. In connection with this engagement, Aadi’s board of directors requested that Leerink Partners evaluate the fairness, from a financial point of view, to Aadi of the consideration proposed to be paid to Aadi pursuant to the terms of the Divestiture Agreement. On December 19, 2024, Leerink Partners rendered to Aadi’s board of directors its oral opinion, which was subsequently confirmed by delivery of a written opinion dated December 19, 2024, that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion, the consideration proposed to be paid to Aadi pursuant to the terms of the Divestiture Agreement was fair, from a financial point of view, to Aadi. The full text of the written opinion of Leerink Partners, dated December 19, 2024, which describes the assumptions made and the qualifications and limitations upon the review undertaken